NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Recurrent or multiple NMIBC
Date of first enrollment	21/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : PMCJ-9(BCG Connaught strain) INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : intravesical instillation

Outcome(s)

Primary Outcome	Recurrence-free survival time, safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 79age old
Gender	Both
Include criteria	1. Granting of written informed consent by the patient 2. Resection of all tumors by TURBT, tumors are histopathologically confirmed NMIBC ( transitional carcinoma). 3. Sufficient function of the major organs 4. Performance status 0-2 etc.
Exclude criteria	1. Muscle-invasive bladder cancer 2. Carcinoma in situ (CIS) or history thereof 3. History of systemic chemotherapy, intra-arterial chemotherapy or radiation therapy for bladder cancer 4. Patient having an immunosuppressive thrapy, etc.